Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
Top Cited Papers
Open Access
- 4 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Genome Medicine
- Vol. 13 (1), 1-14
- https://doi.org/10.1186/s13073-020-00808-4
Abstract
The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late onset Alzheimer’s disease, whilst the ε2 allele confers protection. Previous studies report differential DNA methylation of APOE between ε4 and ε2 carriers, but associations with epigenome-wide methylation have not previously been characterised. Using the EPIC array, we investigated epigenome-wide differences in whole blood DNA methylation patterns between Alzheimer’s disease-free APOE ε4 (n = 2469) and ε2 (n = 1118) carriers from the two largest single-cohort DNA methylation samples profiled to date. Using a discovery, replication and meta-analysis study design, methylation differences were identified using epigenome-wide association analysis and differentially methylated region (DMR) approaches. Results were explored using pathway and methylation quantitative trait loci (meQTL) analyses. We obtained replicated evidence for DNA methylation differences in a ~ 169 kb region, which encompasses part of APOE and several upstream genes. Meta-analytic approaches identified DNA methylation differences outside of APOE: differentially methylated positions were identified in DHCR24, LDLR and ABCG1 (2.59 × 10−100 ≤ P ≤ 2.44 × 10−8) and DMRs were identified in SREBF2 and LDLR (1.63 × 10−4 ≤ P ≤ 3.01 × 10−2). Pathway and meQTL analyses implicated lipid-related processes and high-density lipoprotein cholesterol was identified as a partial mediator of the methylation differences in ABCG1 and DHCR24. APOE ε4 vs. ε2 carrier status is associated with epigenome-wide methylation differences in the blood. The loci identified are located in trans as well as cis to APOE and implicate genes involved in lipid homeostasis.Keywords
Funding Information
- Wellcome Trust (104036/Z/14/Z, 108890/Z/15/Z, 204979/Z/16/Z, 104036/Z/14/Z, 10436/Z/14/Z)
- Medical Research Council (MC_PC_17209)
- Chief Scientist Office, Scottish Government Health and Social Care Directorate (CZD/16/6)
- Brain and Behavior Research Foundation (27404)
- Alzheimer’s Research UK (ARUK-PG2017B-10)
This publication has 70 references indexed in Scilit:
- RegScan: a GWAS tool for quick estimation of allele effects on continuous traits and their combinationsBriefings in Bioinformatics, 2013
- Pedigree and genotyping quality analyses of over 10,000 DNA samples from the Generation Scotland: Scottish Family Health StudyBMC Medical Genetics, 2013
- Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illnessInternational Journal of Epidemiology, 2012
- GCTA: A Tool for Genome-wide Complex Trait AnalysisAmerican Journal of Human Genetics, 2011
- METAL: fast and efficient meta-analysis of genomewide association scansBioinformatics, 2010
- The effect of APOE genotype on brain levels of oxysterols in young and old human APOE ε2, ε3 and ε4 knock-in miceNeuroscience, 2010
- ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivoJournal of Lipid Research, 2008
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993